OrganiGram’s Q2 2020 Earnings Show a Company Running Out of Cash

Marijuana – Grizzle     •     April 14, 2020, 12:32 pm
Organigram is running suprisingly low on cash. Negotiations with its lenders will determine where the stock price goes from here.


Popular posts from this blog

Johns Hopkins Will Test Epidiolex to See If It Can Help with Opioid Withdrawal

Pregnant women and providers grapple with how to talk about marijuana

How to Protect Your Brand From Counterfeiters